Cadence Capital Management’s Vascular Solutions Inc VASC Stock Holding History

Cadence Capital Management’s Portfolio VASC Stock Details VASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-21,235	Closed	-$1.02M	–	722
2016 Q3	$1.02M	Sell	21,235 -150	-0.7%	-$6.99K	0.07%	304
2016 Q2	$891K	Buy	+21,385	New	+$796K	0.07%	316
2014 Q4	–	Sell	-54,160	Closed	-$1.34M	–	690
2014 Q3	$1.34M	Sell	54,160 -1,490	-3%	-$35.3K	0.07%	327
2014 Q2	$1.24M	Buy	+55,650	New	+$1.22M	0.06%	370

Other funds holding VASC

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Cadence Capital Management's VASC Position: Q4 2016 in Review

Cadence Capital Management sold out of Vascular Solutions Inc (VASC) in Q4 2016, closing a stake of 21,235 shares — an estimated $1.02M sold.

Cadence Capital Management first reported a position in VASC in Q2 2014 and held it in 4 quarters. The position peaked at $1.34M in Q3 2014. 163 funds tracked by Wall St. Rank hold VASC as of Q4 2016.

Cadence Capital Management reported no remaining Vascular Solutions Inc position as of Q4 2016 after selling out during the quarter.
Cadence Capital Management sold 21,235 Vascular Solutions Inc shares in Q4 2016, an estimated $1.02M.
Cadence Capital Management first reported a position in Vascular Solutions Inc in Q2 2014 and held it in 4 quarters.
Cadence Capital Management's Vascular Solutions Inc position peaked at $1.34M in Q3 2014.
163 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q4 2016.

Based on Cadence Capital Management's 13F filing for Q4 2016, filed 1 Feb 2017.